Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin To prevenT Infection in chronic liveR failurE (ATTIRE) feasibility trial
2014-002300-24Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of albumin (human) in Cirrhosis and acute-on-chronic liver failure (ACLF), sponsored by University College London. Primary endpoint: Feasibility outcomes (primary). Started Jan 2015; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cirrhosisacute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on 2014-002300-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002300-24.